Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Oral metronomic cyclophosphamide and methotrexate plus fulvestrant in advanced breast cancer patients: a mono-institutional case-cohort report.
Aurilio G, Munzone E, Botteri E, Sciandivasci A, Adamoli L, Minchella I, Esposito A, Cullurà D, Curigliano G, Colleoni M, Goldhirsch A, Nolè F. Aurilio G, et al. Among authors: minchella i. Breast J. 2012 Sep;18(5):470-4. doi: 10.1111/j.1524-4741.2012.01278.x. Epub 2012 Jul 25. Breast J. 2012. PMID: 22827581 Clinical Trial.
Pre-operative chemotherapy and radiotherapy in breast cancer.
Colleoni M, Nole F, Minchella I, Noberasco C, Luini A, Orecchia R, Veronesi P, Zurrida S, Viale G, Goldhirsch A. Colleoni M, et al. Among authors: minchella i. Eur J Cancer. 1998 Apr;34(5):641-5. doi: 10.1016/s0959-8049(97)10091-0. Eur J Cancer. 1998. PMID: 9713267
Prediction of response to primary chemotherapy for operable breast cancer.
Colleoni M, Orvieto E, Nolé F, Orlando L, Minchella I, Viale G, Peruzzotti G, Robertson C, Noberasco C, Galimberti V, Sacchini V, Veronesi P, Zurrida S, Orecchia R, Goldhirsch A. Colleoni M, et al. Among authors: minchella i. Eur J Cancer. 1999 Apr;35(4):574-9. doi: 10.1016/s0959-8049(99)00005-2. Eur J Cancer. 1999. PMID: 10492630
Primary chemotherapy in operable breast cancer with favorable prognostic factors: a pilot study evaluating the efficacy of a regimen with a low subjective toxic burden containing vinorelbine, 5-fluorouracil and folinic acid (FLN).
Nolè F, Minchella I, Colleoni M, Orvieto E, Munzone E, de Braud F, Peruzzotti G, Martinelli G, Zampino MG, Catania C, Pizzamiglio M, Veronesi P, Zurrida S, Galimberti V, Goldhirsch A, Veronesi U. Nolè F, et al. Among authors: minchella i. Ann Oncol. 1999 Aug;10(8):993-6. doi: 10.1023/a:1008389106575. Ann Oncol. 1999. PMID: 10509165 Free article. Clinical Trial.
Mediastinal lymphoadenopathy in a patient with breast cancer.
Curigliano G, Mandala M, Minchella I, Goldhirsch A. Curigliano G, et al. Among authors: minchella i. Lancet Oncol. 2002 Mar;3(3):174. doi: 10.1016/s1470-2045(02)00681-2. Lancet Oncol. 2002. PMID: 11902504 No abstract available.
Preoperative and perioperative chemotherapy with 5-fluorouracil as continuous infusion in operable breast cancer expressing a high proliferation fraction: cytotoxic treatment during the surgical phase.
Colleoni M, Curigliano G, Minchella I, Peruzzotti G, Nolè F, Mazzarol G, Renne G, Orlando L, Rocca A, Veronesi P, Intra M, Viale G, Sandri MT, Severi G, Goldhirsch A. Colleoni M, et al. Among authors: minchella i. Ann Oncol. 2003 Oct;14(10):1477-83. doi: 10.1093/annonc/mdg411. Ann Oncol. 2003. PMID: 14504046 Free article. Clinical Trial.
41 results